Stockreport

Benitec launches mid-stage study of BB-401 in HNSCC; shares up 4% [Seeking Alpha]

Benitec Biopharma Inc.  (BNTC) 
US:NASDAQ Investor Relations: benitec.com/for-investors/investor-faqs
PDF Benitec launches mid-stage study of BB-401 in HNSCC; shares up 4%Thinly traded nano cap Benitec Biopharma (BNTC+4.2%)commences an Australia and Russia-basedPhase 2 clini [Read more]